Analysis of tissue factor and tissue factor pathway inhibitor expression in human colorectal carcinoma cell lines and metastatic sublines to the liver

International Journal of Cancer

Volumn 72, Issue 5, 1997, Pages 878-884

  Kataoka, Hiroaki ^a   Uchino, Hirofumi ^a   Asada, Yujiro ^a   Hatakeyama, Kinta ^a   Nabeshima, Kazuki ^a   Sumiyoshi, Akinobu ^a   Koono, Masashi ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIVER METASTASIS; METASTASIS POTENTIAL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; BLOTTING, NORTHERN; COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOPROTEINS; LIVER NEOPLASMS; RNA, MESSENGER; SERINE PROTEINASE INHIBITORS; THROMBOPLASTIN; TUMOR CELLS, CULTURED;

EID: 0030860561     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970904)72:5<878::AID-IJC27>3.0.CO;2-3     Document Type: Article

References (30)

1. BAJAJ , M.S., KUPPUSWAMY, M.N., SAITO, H., SPITZER, S.G. and BAJAJ, S.P., Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. Proc. nat. Acad. Sci. (Wash.), 87, 8869-8873 (1990).
2. BAZAN, J.F., Structural design and molecular evolution of a cytokine receptor superfamily. Proc. nat. Acad. Sci. (Wash.), 87, 6934-6938 (1990).
3. BROMBERG, M.E., KONIGSBERG, W.H., MADISON, J.F., PAWASHE, A. and GAREN, A., Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc. nat. Acad. Sci. (Wash.), 92, 8205-8209 (1995).
4. BROZE, G.J., JR., GIRARD, T.J. and NOVOTNY, W.F., Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry, 29, 7539-7546 (1990).
5. CALLANDER, N.S., VARKI, N. and RAO, L.V.M., Immunohistochemical identification of tissue factor in solid tumors. Cancer, 70, 1194-1201 (1992).
6. CARSON, S.D. and ARCHER, P.G., Tissue factor activity in HeLa cells measured with a continuous chromogenic assay and ELISA reader. Thrombosis Res., 41, 185-195 (1986).
7. CHIANG, H.S., YANG, R.S. and HUANG, T.F., Thrombin enhances the adhesion and migration of human colon adenocarcinoma cells via increased β3-integrin expression on the tumour cell surface and their inhibition by the snake venom peptide, rhodostomin. Brit. J. Cancer, 70, 902-908 (1996).
8. CONTRINO, J., HAIR, G., KREUTZER, D.L. and RICKLES, F.R., In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nature (Med.), 2, 209-215 (1996).
9. DRAKE, T.A., MORRISSEY, J.H. and EDGINGTON, T.S., Selective cellular expression of tissue factor in human tissues: implication for disorders of hemostasis and thrombosis. Amer. J. Pathol., 134, 1087-1097 (1989).
10. ESUMI, N., FAN, D. and FIDLER, I.J., Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. Cancer Res., 51, 4549-4556 (1991).
11. GIRARD, T.J., WARREN, L.A., NOVOTNY, W.F., BEJCHK, B.E., MILETICH, J.P. and BROZE, G.J., JR., Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein. Thrombosis Res., 55, 37-50 (1989).
12. GORDON, S.G., FRANKS, J.J. and LEWIS, B., Cancer procoagulant A: a factor activating procoagulant from malignant tissue. Thrombosis Res., 6, 127-137 (1975).
13. GUNJI, Y. and GORELIK, E., Fibrin protects murine tumor cells from destruction by killer cells. Cancer Res., 48, 5216-5221 (1988).
14. HAMADA, K., KURATSU, J., SAITOH, Y., TAKESHIMA, H., NISHI, T. and USHIO, Y., Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer, 77, 1877-1883 (1996).
15. HARTZELL, S., RYDER, K., LANAHAN, A., LAU, L.F. and NATHANS, D., A growth factor-responsive gene of murine BALB/c 3T3 cells encodes a protein homologous to human tissue factor. Mol. cell. Biol. 9, 2567-2573 (1989).
16. KANEKO, Y., KOURA, M. and YOSHII, H., Characterization of a newly established, human rectal adenocarcinoma cell line. Acta med. Univ. Kagoshima, 19, 71-81 (1977).
17. KOHANNA, F.H., SWEENEY, J., HUSSEY, S., ZACHARSKI, L.R. and SALZMAN, E., Effects of perioperative low-dose heparin administration on the course of colon cancer. Surgery; 93, 433-438 (1983).
18. LOGT, C.P.E., REITSMA, P.H. and BERTINA, R.M., Alternative splicing is responsible for the presence of two tissue factor mRNA species in LPS stimulated human monocytes. Thrombosis Haemostasis, 67, 272-276 (1992).
19. MARUTSUKA, K., SUZUMIYA, J., KATAOKA, H., KOMADA, N., KOONO, M. and SUMIYOSHI, A., Correlation between urokinase-type plasminogen activator production and the metastatic ability of human rectal cancer cells. Invasion Metastasis, 11, 181-191 (1991).
20. MUELLER, B.M., REISFELD, R.A., EDGINGTON, T.S. and RUF, W., Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc. nat. Acad. Sci. (Wash.). 89, 11832-11836 (1992).
21. NEMERSON, Y., Tissue factor and hemostasis. Blood, 71, 1-8 (1988).
22. NOVOTNY, W.F., BROWN, S.G., MILETICH, J.P., RADAR, D.J. and BROZE, G.J., JR., Plasma antigen levels of the lipoprotein associated coagulation inhibitor in patient samples. Blood, 78, 387-393 (1991).
23. NOVOTNY, W.F., GIRARD, T.J., MILETICH, J.P. and BROZE, G.J., JR., Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood, 72, 2020-2025 (1988).
24. RAO, L.V.M., Tissue factor as a tumor procoagulant, Cancer Metastasis Rev., 11, 249-266 (1992).
25. SPICER, E.K., HORTON, R., BLOEM, L., BACH, R., WILLIAMS, K.R., GUHA, A., KRAUS, J., LIN, T.-H., NEMERSON, Y. and KONIGSBERG, W.H., Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc. nat. Acad. Sci. (Wash.), 84, 5148-5152 (1987).
26. TROUSSEAU, A., Phlegmasia alba dolens: clinique médicale de l'Hôtel-Dieu de Paris. N. Sydenham Soc., 3, 94 (1865).
27. VRANA, J.A., STANG, M.T., GRANDE, J.P. and GETZ, M.J., Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell-derived members of the transforming growth factor β family. Cancer Res., 56, 5063-5070 (1996).
28. WALTZ, D.A. and FENTON, J.W., The role of thrombin in tumor cell metastasis. Invasion Metastasis 14, 303-308 (1995).
29. ZHANG, Y., DENG, Y., LUTHER, T., MÜLLER, M., ZIEGLER, R., WALDHERR, R., STERN, D.M. and NAWROTH, P.P., Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J. clin. Invest., 94, 1320-1327 (1994).
30. ZIONCHECK, T.F., ROY, S. and VEHAR, G.A., The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism. J. biol. Chem., 267, 3561-3564 (1992).